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Systematic review of mental health interventions for
patients with common somatic symptoms: can research
evidence from secondary care be extrapolated to primary
care?
Rosalind Raine, Andy Haines, Tom Sensky, Andrew Hutchings, Kirsten Larkin, Nick Black,
Abstract
Objectives To determine the strength of evidence for
the effectiveness of mental health interventions for
patients with three common somatic conditions
(chronic fatigue syndrome, irritable bowel syndrome,
and chronic back pain). To assess whether results
obtained in secondary care can be extrapolated to
primary care and suggest how future trials should be
designed to provide more rigorous evidence.
Design Systematic review.
Data sources Five electronic databases, key texts,
references in the articles identified, and citations from
expert clinicians.
Study selection Randomised controlled trials
including participants with one of the three
conditions for which no physical cause could be
found. Two reviewers screened sources and
independently extracted data and assessed quality.
Results Sixty one studies were identified; 20 were
classified as primary care and 41 as secondary care.
For some interventions, such as brief psychodynamic
interpersonal therapy, little research was identified.
However, results of meta›analyses and of randomised
controlled trials suggest that cognitive behaviour
therapy and behaviour therapy are effective for
chronic back pain and chronic fatigue syndrome and
that antidepressants are effective for irritable bowel
syndrome. Cognitive behaviour therapy and
behaviour therapy were effective in both primary and
secondary care in patients with back pain, although
the evidence is more consistent and the effect size
larger for secondary care. Antidepressants seem
effective in irritable bowel syndrome in both settings
but ineffective in chronic fatigue syndrome.
Conclusions Treatment seems to be more effective in
patients in secondary care than in primary care. This
may be because secondary care patients have more
severe disease, they receive a different treatment
regimen, or the intervention is more closely supervised.
However, conclusions of effectiveness should be
considered in the light of the methodological
weaknesses of the studies. Large pragmatic trials are
needed of interventions delivered in primary care by
appropriately trained primary care staff.
Introduction
As many as one in five new consultations in primary
care are for somatic symptoms for which no specific
cause can be found.1 Patients with such symptoms
often become frequent attenders, and their manage›
ment poses considerable challenges for both general
practitioners and specialists.2 Although systematic
reviews have shown that certain mental health
interventions are effective in these patients, the
treatments are not always provided.3–6 This may be
partly because general practitioners question the qual›
ity of the evidence and its relevance for their patients or
because the evidence of effectiveness is not widely
known.7–9 Much of the research has been carried out in
specialist settings, as is often the case when
management is shared between primary and second›
ary care, and findings from specialist settings may not
be applicable to primary care.
We did this study to investigate whether there is
good evidence that mental health interventions are
effective for patients with common somatic symptoms
and whether the results of trials in secondary care can
be extrapolated to primary care. We selected three
common somatic conditions for which general
practitioners had indicated they would welcome
guidance: chronic fatigue syndrome, irritable bowel
syndrome, and chronic back pain.10 In assessing the
quality of published research, we also sought to identify
how future trials should be designed to provide more
rigorous evidence.
Method
We undertook a systematic review of randomised con›
trolled trials, systematic reviews, and meta›analyses of
mental health interventions for chronic fatigue
syndrome, irritable bowel syndrome, and chronic back
pain.
Search strategy
We searched PubMed, the Cochrane Library, PsycLIT,
and Embase for English language papers published
between 1966 and September 2001. We looked at the
references cited in the identified meta›analyses,
systematic reviews, and individual studies to find
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further studies and also searched key texts.9 11 Six
liaison psychiatrists, who were known to have an inter›
est in functional somatic complaints, were asked to cite
relevant literature. Box 1 gives the full search strategy
Inclusion criteria
We identified published studies of cognitive behaviour,
cognitive, behaviour, brief interpersonal psychody›
namic, and antidepressant therapy. For analysis of the
randomised controlled trials, we pooled cognitive
behaviour and cognitive therapy because there is no
practical distinction between them and the studies gave
insufficient details about the interventions to validate
any distinction. Studies that included subjects whose
symptoms were attributable to physical disease were
excluded.
Data extraction and assessment of study quality
One of us (RR) extracted data from the identified
papers and a second reviewer checked them (KL). Dis›
crepancies were resolved by referring to the original
studies. We extracted data on the source of the patient
sample; patient characteristics; the intervention and
comparison treatment and who carried them out; out›
comes; and study dropouts and reasons for withdrawal.
Studies were defined as primary care studies if they
included patients who were recruited from the
community or through their primary care physician.
Ten studies included a mixture of primary and second›
ary care patients, and these were classified as primary
care studies.12–21
Both reviewers independently noted methodologi›
cal details using a checklist including randomisation,
blinding of those assessing outcomes, and handling of
attrition in the analysis. The methodological quality of
much of this literature has been previously systemati›
cally assessed using quality scales.3–5 However, the
scales vary in the dimensions covered and their
complexity. We therefore assessed the relevant
methodological aspects individually rather than use a
composite score.22
Outcome measures and analysis
For all studies, we compared the findings of research
from each setting by tabulating the reported health
status and functional outcomes (tables 1›3). We
compared initial disease severity of patients and treat›
ment effect sizes between settings when studies used
similar interventions and the same health status meas›
ures. In the limited number of cases in which we could
compare primary and secondary care patients using
the same outcome measure, the severity in each study
was calculated by combining patients from all
treatment arms. We calculated treatment effect sizes
with 95% confidence intervals from the difference in
mean health status after treatment and standardised
them using Cohen’s d.23 We combined treatment effects
using fixed effects meta›analysis when two or more
studies from the same setting used the same health
status measure. A random effects meta›analysis was
used if there was significant heterogeneity (P < 0.05) of
study effect sizes.
Results
We identified 61 randomised controlled studies12›21 24›81
and two meta›analyses: one on the effectiveness of
behaviour therapy for chronic back pain, and one on
the effectiveness of antidepressants for irritable bowel
syndrome.3 4 One third (20) of the randomised
controlled studies were defined as primary care studies
(table 4). This included eight studies of patients who
had been recruited solely through their primary care
physician.13 17 18 21 25 40 60 68 A further eight studies
included patients who were recruited in two ways
within the same trial: either by their primary care
physician or self referred after media publi›
city.12 14–16 19 20 37 41 The authors did not distinguish the
Box 1: Literature search strategy
Step 1: Computer assisted literature searches of the
bibliographic databases: PubMed, Cochrane
Collaboration database, Embase, and PsychLit for
papers published between 1966 and September 2001
using the following search terms:
• Somati* (and) treatment (or) therapy (or)
rehabilitation (or) drug* (or) management (or)
intervention
• Somatoform (and) treatment (or) therapy (or)
rehabilitation (or) drug* (or) management (or)
intervention
• Abnormal illness behaviour (and) treatment (or)
therapy
• Medically (near) unexplained symptom* (and)
treatment (or) therapy
• Psychophysiologic (and) treatment
• Psychogenic (and) treatment
• (Functional (near) symptom* (or) illness) and
(treatment (or) therapy)
• Unaccounted medical symptoms (and) treatment
(or) therapy
• Pain syndromes (and) treatment
All of the above searches were combined with (or
stepwise limits conducted in PubMed): (i)meta›analysis,
(ii) review, (iii) randomi*ed control*, (iv) control* trial
Additional searches combined the following key
terms:
• Chronic fatigue (or) irritable bowel (or) chronic back
pain
• Treatment (or) therapy (or) rehabilitation (or) drug*
(or) management (or) intervention
• Randomised controlled (or) RCTKL selected the
trials to be included using the broad selection criteria
(outlined above) and RR then selected relevant articles
using the following criteria:
• Randomised controlled studies on chronic fatigue
syndrome, irritable bowel syndrome, or chronic back
pain
• Mental health interventions
• Adult study populations ( > 18 years)
• Studies reported in English language
• Patients with symptoms attributable to physical
disease were excluded from study
Step 2: The references contained in articles identified
in step 1 were examined to identify further relevant
studies.
Step 3: Relevant references in the Department of
Health Report Treatment Choice in Psychological
Therapies and Counselling: Evidence Based Clinical
Practice Guideline, and in Mayou et al were identified.11
Step 4: Six liaison psychiatrists who have a special
interest in this area were asked to cite relevant
literature.
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source of referral when presenting their results. A fur›
ther four studies recruited volunteers, but the inclusion
criteria of two of these studies specified that
participants must have had sick leave for their somatic
symptom, and in the third study, the general
practitioner was contacted to exclude organic dis›
ease.39 41 77 The conclusions are summarised in box 2.
Treatments evaluated in primary and secondary
care
Back pain
The effectiveness of cognitive behaviour therapy and
behaviour therapy has been measured in both primary
and secondary care patients. Of 16 studies of cognitive
behaviour therapy for patients with back pain, seven
were in primary care (891 patients) and nine in
secondary care (625 patients). Patients from both
settings reported sustained improvements in pain, dis›
ability, and depression.17 19 20 24–36 A meta analysis of the
effectiveness of behaviour therapy found a moderate
positive effect on intensity of pain and a small positive
effect on behavioural outcomes in patients, regardless
of setting.3 Behaviour therapy also seems to be effective
in both primary and secondary care. Eight out of nine
primary care studies on 659 patients and five out of six
secondary care studies with a total of 398 patients
reported improvements in symptoms.17 19 20 26 28 29 37–43
There was some evidence from both settings that these
Table 1 Literature review of mental health interventions for chronic fatigue syndrome
Study No of participants Intervention group Control or comparison group
Outcomes*
Short term (0›6 months) Medium term (>6 months)
Cognitive behaviour therapy†
Patients from primary care or community:
Ridsdale
(2001)60
160 Cognitive behaviour therapy Non›directive counselling No significant difference in fatigue,
anxiety, depression, social adjustment,
use of antidepressants, or
consultations. No significant difference
in cost effectiveness
Patients from secondary care:
Prins
(2001)56
278 Cognitive behaviour therapy Support, no intervention 14 month follow up: decrease in
fatigue severity and increase in
functional support
Deale
(1997)57
(2001)79
60 Cognitive behaviour therapy Relaxation Increase in functional status and social
adjustments, decrease in fatigue, no
significant difference in depression and
general health
5 year follow up: increase in those
reporting “(very) much better,”
complete recovery, no relapses, and
symptom improvement. No significant
difference in fatigue or mental health.
Only 26% patients judged completely
recovered
Sharpe
(1996)58
60 Cognitive behaviour therapy Medical care 12 month follow up: improved
functional status and coping, decrease
in illness cognitions, depression
improved non›significantly
Lloyd
(1993)59
90 Cognitive behaviour therapy (with
spouse) with or without
immunological therapy
Placebo with or without attending
clinic
No significant difference in physical
capacity, functional status, or
psychological morbidity
Behaviour therapy
Patients from secondary care:
Powell
(2001)67
148 Behaviour therapy (graded
exercise)
Medical care 12 month follow up: increase in
physical functioning, decrease in
fatigue, and increased belief that
chronic fatigue syndrome is related to
physical deconditioning
Wearden
(1998)45
132 Behaviour therapy (graded
exercise) + selective serotonin
reuptake inhibitor
Exercise + placebo or review
appointment + SSRI or review
appointment + placebo
Exercise increased functional work
capacity but no improvement in
depression
Fulcher
(1997)66
66 Behaviour therapy (graded
exercise)
Relaxation and stretching Decrease in fatigue, increase in
functional capacity and general health
Antidepressants‡
Patients from primary care or community:
Vercoulen
(1996)12
96 Selective serotonin reuptake
inhibitors (therapeutic dose)
Placebo No significant difference in depression,
wellbeing, fatigue, functional status,
sleep disturbances, neuropsychological
functioning, social interactions, or
cognition
Patients from secondary care:
Hickie
(2000)44
90 Monoamine oxidase inhibitors Placebo Increase in vigour, no significant
difference in disability, fatigue, and
depression
Wearden
(1998)45
132 Selective serotonin reuptake
inhibitors + behaviour therapy
(graded exercise)
Exercise + placebo or review
appointment + selective serotonin
reuptake inhibitor or review
appointment + placebo
Serotonin reuptake inhibitors: improve
depression but no improvement in
fatigue or functional work capacity
Natelson
(1996)46
18 Monoamine oxidase inhibitors Placebo Improvements on composite measure
of symptoms, illness severity, mood,
functional status no improvements in
above individual measures
*Reported changes in outcome are significant (P<0.05) unless stated otherwise.
†Studies reporting the use of cognitive therapy are reported under cognitive behaviour therapy because behaviour techniques were also used in the intervention.
‡All antidepressants were administered at established therapeutic levels (British National Formulary, 2001) unless otherwise stated.
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improvements were sustained at one year follow
up.18 39 41 The initial health status of secondary care
patients was poorer than that of patients in primary
care (table 5) but they reported greater improvements
(figs 1 and 2, table 6).
Table 2 Literature review of mental health interventions for irritable bowel syndrome
Study
No of
participants Intervention group Control or comparison group
Outcomes*
Short term (0›6 months) Medium term (>6months)
Cognitive behaviour therapy/cognitive therapy
Patients from primary care or the community:
Payne
(1995)13
34 Cognitive behaviour therapy Self help, symptom monitoring Decrease in pain, tenderness, & diarrhoea.
Delayed decrease in depression & anxiety at
3 months
Greene
(1994)14
20 Cognitive behaviour therapy Symptom monitoring Improvement in composite score
Blanchard
(1992)16
115 Cognitive behaviour therapy Attention placebo, symptom monitoring Attention placebo: No significant difference in
composite symptom score, trait anxiety, &
depression
Symptom monitoring: no improvement
Patients from secondary care:
Van
Dulmen
(1996)61
47 Cognitive behaviour therapy Waiting list control group Fall in duration & severity of pain, avoidance
behaviours, increase in coping, no significant
difference in psychological well being
2 year follow up: Decrease in duration of
pain & severity and avoidance behaviours
Rumsey
(1991)62
45 Cognitive behaviour therapy Standard medical treatment Decreased anxiety & depression
Lynch
(1989)63
27 Cognitive behaviour therapy Waiting list control group Decrease in composite symptom score &
depression, decrease in individual symptom:
discomfort & constipation
Neff
(1987)64
19 Cognitive behaviour therapy Symptom monitoring Fall in composite symptom score and in
flatulence
Bennett
(1985)65
33 Cognitive behaviour therapy Tricyclic antidepressants, antianxiety
drugs, laxative
Decrease in anxiety, pain, discomfort,
motions, & abnormal motions
Behaviour therapy
Patients from primary care or the community:
Keefer
(2001)68
16 Behaviour therapy Symptom monitoring Decrease in composite symptom score
Blanchard
(1993)15
23 Behaviour therapy Symptom monitoring Decrease in composite symptom score and
abdominal pain
Patients from secondary care:
Shaw
(1991)69
35 Behaviour therapy Antispasmodic drugs Decrease in frequency & severity of pain
Corney
(1990)70
42 Behaviour therapy Standard medical treatment No significant difference in gastrointestinal
symptoms & psychological outcomes
Antidepressants
Patients from primary care or the community:
Myren
(1984)47
428 Tricyclic antidepressants Placebo Decrease in abdominal pain, acid, nausea &
depression
Patients from secondary care:
Rajagopalan
(1998)49
40 Tricyclic antidepressants Placebo Decrease in pain, increase in global well›
being and satisfaction with bowel movements
Mertz
(1998)50
7 Tricyclic antidepressants
(subtherapeutic dose)
Placebo Decrease in severe gastrointestinal
symptoms, no improvements to sensory
feelings of fullness, discomfort or pain
(under laboratory conditions)
Tanum
(1996)51
49 Mianserin Placebo Decrease in pain, abdominal distress, &
functional disability
Vij (1991)48 50 Tricyclic
antidepressants
Placebo Decrease in pain, constipation, incomplete
bowel evacuation, & diarrhoea
Alevizos
(1989)52
40 Tricyclic
antidepressants
Placebo Non›significant improvements in mood,
retardation, & cognitive function
Greenbaum
(1987)53
41 Tricyclic antidepressants Placebo or atropine Decrease in stool frequency, diarrhoea, pain,
slow rectal contractions, & depression in
diarrhoea›prone patients
Tripathi
(1983)55
50 Tricyclic antidepressants
(subtherapeutic dose)
Placebo Increase in gastrointestinal improvement
Myren
(1982)47
61 Tricyclic antidepressants Placebo Decrease in vomiting, sleeplessness, mucus
in stools, & depression. No improvement for
tiredness, anxiety, nausea, belching,
headache, & composite improvement
measure
Lancaster›Smith
(1982)78
48 Combined anxiolytic/tricyclic
antidepressants + bran
Placebo + bran Decrease in abdominal pain & diarrhoea. No
improvement: constipation or sensation of
distension
Steinhart
(1981)80
14 Tricyclic antidepressants
(subtherapeutic dose)
Placebo No difference in composite symptom score
Heffner
(1978)54
44 Tricyclic antidepressants Placebo Decrease in bowel movement irregularities &
interference with daily life. No significant
difference in depression, pain/discomfort
Brief psychodynamic interpersonal therapy
Patients from secondary care:
Guthrie
(1993) &
(1991)71 72
102 Brief psychodynamic interpersonal
therapy
Supportive listening + laxative +
antispasmodic drug
Decrease in abdominal pain & diarrhoea 1 year follow up: Decrease in depression,
psychiatric status & symptoms in women
only (non›significant falls for men)
Svedlund
(1985) &
(1983)73 74
101 Brief psychodynamic interpersonal
therapy + antispasmodics
Antispasmodic drug 1 year follow up: Decrease in pain and
dysfunction
15 month follow up: Decrease in
gastrointestinal symptoms composite score
*All changes are significant (P<0.05) unless stated otherwise.
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Table 3 Literature review of mental health interventions for chronic back pain
Study
No of
participants Intervention group Control or comparison group
Outcomes*
Short term (0›6 month) Medium term (>6 month)
Cognitive behaviour therapy/cognitive therapy
Patients from primary care or the community:
Moore
(2000)25
226 Group cognitive behaviour therapy Usual medical care & information Decrease in pain & disability, interference in activities,
worries, and fear avoidance beliefs
1 year follow up: decrease in worries & fear avoidance
beliefs maintained
Linton
(2000)81
243 Group cognitive behaviour therapy Pamphlet of advice
or information package
1 year follow up: no significant difference in pain,
decreased healthcare use & sick leave
Rose
(1997)18
84 15 hours’ individual
therapy
Group therapy, 30 or 60 hours No significant difference in improvements in pain,
disability, depression, control, somatic
awareness/distress, & self efficacy for both duration &
group/individual
Newton›John
(1995)17
44 Group cognitive behaviour therapy Group behaviour therapy or waiting list control Decrease in pain intensity & depression. Increase in
adaptive cognitions
Bru
(1994)39
111 Group cognitive behaviour therapy Behaviour therapy, cognitive behaviour therapy,
or waiting list control
Decrease in pain intensity in neck and low back.
Improvements in low back pain show relapse at 4
month follow up
Turner
(1993)19
102 Group cognitive behaviour therapy Group behaviour therapy
or waiting list control
1 year follow up: decreased pain intensity, depression,
& disability
Turner
(1988)20
81 Group cognitive behaviour therapy Group behaviour therapy
or waiting list control
Decrease in pain behaviour + physical & psychosocial
dysfunction
1 year follow up: sickness impact & pain behaviour
continue to improve
Patients from secondary care:
Kole›Snijders
(1999)26 &
Goossens
(1998)27
148 Group cognitive behaviour therapy Individual behaviour therapy (with spouse),
individual behaviour therapy (without spouse), or
waiting list control
Decrease in negative affect and increase in coping &
overall health measure.
6 month follow up: further improvement in motor
behaviour
1 year follow up: no significant difference in negative
affect, motor behaviour, coping, or costs & overall
health between intervention groups
Strong
(1998)24
30 Individual cognitive behaviour therapy +
usual treatment (pain control, psychiatry,
occupational therapy & physiotherapy)
Usual treatment (pain control, psychiatry,
occupational therapy & physiotherapy)
Increased control over pain, use of coping. Decreased
helplessness, depression, disability, pain intensity (not
sustained at 3 months)
Bendix
(1997,98,
98)32›35
123 Cognitive behaviour therapy (group
multidisciplinary)
Cognitive behaviour therapy (coping & behaviour
therapy)
or cognitive behaviour therapy (physical training
+ back school)
1 year follow up: multidisciplinary group showed
decrease in healthcare use, back pain, disability, and
analgesia use. Increase in work›ready rate. No
difference between other two groups.
5 year follow up: multidisciplinary group showed
improvements in working and daily activities.
Basler
(1997)36
94 Cognitive behaviour therapy + standard
medical treatment
Standard medical treatment Decrease in pain, avoidance behaviour, &
catastrophising.
Increase in pleasurable activities + feelings, control
over pain, social disability, mental performance,
functional capacity.
Vlaeyen
(1995)28
71 Cognitive behaviour therapy (part group,
part individual)
Behaviour therapy (part group, part individual)
or waiting list control
Decrease in pain behaviours, mood, cognitions
(catastrophising). Improved functional status. No
significant difference in depression & pain intensity
Altmaier
(1992)31
45 Cognitive behaviour therapy + education,
support, exercise (part group, part
individual)
Education, support + exercise (part group, part
individual)
No effect on disability, pain intensity, levels of
interference of pain (including mood) & return to work
Nicholas
(1992)30
20 Group cognitive behaviour therapy +
physiotherapy
Group physiotherapy + discussion Increase in coping & functioning,
decrease in sickness impact & medication use
Nicholas
(1991)29
58 Group cognitive behaviour therapy +/−
relaxation
Group behaviour therapy +/− relaxation
or physiotherapy + discussion
or physiotherapy only
1 year follow up: no significant difference in pain
intensity, functional status, cognitions, use of active
coping.
Turner
(1982)43
36 Group cognitive behaviour therapy Group behaviour therapy
or waiting list control
Fall in pain, disability, depression 2 year follow up: decrease in healthcare use, increase
in time spent working
Behaviour therapy
Patients from primary care or the community:
Newton›John
(1995)17
44 Group behaviour therapy Group cognitive behaviour therapy
or waiting list control
Fall in pain intensity & depression, increase in
adaptive cognitions
Bru
(1994)39
111 Group behaviour therapy Group cognitive behaviour therapy
or waiting list control
Fall in pain intensity in low back pain
Donaldson
(1994)38
36 Behaviour therapy (biofeedback)
36 participants
Relaxation
or education
Decreased pain in behaviour therapy (biofeedback)
only
Turner
(1993)19
102 Group behaviour therapy Group cognitive behaviour therapy
or waiting list control
1 year follow up: decrease in pain intensity,
depression, disability. No difference between
intervention groups
Lindstrom
(1992)40
103 Behaviour therapy Analgesics, some “preset” physiotherapy, rest Return to work earlier 1 year follow up: less time off work, fewer symptoms
Turner
(1990)37
96 Group behaviour therapy (with spouse) +
group exercise
Group exercise
or group behaviour therapy (with spouse),
or waiting list control
Decrease in pain behaviour and physical and
psychosocial disability
1 year follow up: no difference in improvement
between intervention groups
Linton
(1989)41
66 women only Group behaviour therapy Waiting list control Decrease in pain, fatigue, anxiety, negative mood.
Increase in sleep and activity level
Turner
(1988)20
81 Group behaviour therapy Group cognitive behaviour therapy Decreased pain behaviour + physical & psychosocial
dysfunction but no significant difference in pain
severity
1 year follow up: improvements in sickness impact &
pain behaviour level off
Nouwen
(1983)77
20 Behaviour therapy (biofeedback) Waiting list control No significant effect on pain
Patients from secondary care:
Kole›Snijders
(1999) &
Goossens
(1998)26 27
148 Individual behaviour therapy (with spouse) Group cognitive behaviour therapy,
individual behaviour therapy (without spouse), or
waiting list control
Compared with behaviour therapy (with or without
spouse): decreased negative affect and increase in
coping & overall health measure
1 year follow up: no significant difference in negative
affect, motor behaviour, or coping between
intervention groups
Vlaeyen
(1995)28
71 Behaviour therapy (part group, part
individual)
Cognitive behaviour therapy (part group, part
individual)
or waiting list control
Decrease in pain behaviours, negative mood, and
cognitions (catastrophising). Increase in functional
status, no significant difference in depression & pain
intensity
Altmaier
(1992)31
45 Education, support + exercise (considered
here to be behaviour therapy) (part group,
part individual)
Cognitive behaviour therapy + education,
support, exercise (part group, part individual)
No significant difference in improvements in disability,
pain intensity, levels of interference of pain (including
mood) & return to work
Nicholas
(1991)29
58 Group behaviour therapy +/− relaxation Group cognitive behaviour therapy +/− relaxation
or physiotherapy + discussion
or physiotherapy only
Improvement in functional status, pain beliefs, and
coping
1 year follow up: no significant difference in functional
status, pain beliefs, & intensity and coping
Philips
(1987)42
40 Behaviour therapy (pain management) Waiting list control 1 year follow up: decrease in pain avoidance
behaviours, affective reaction to pain & depression.
Increased control over pain.
Turner
(1982)43
36 Group behaviour therapy Group cognitive behaviour therapy
or waiting list control
Decrease in pain, disability, and depression. 2 year follow up: decreased healthcare use, increase
in time spent working
Antidepressants
Patients from secondary care:
Loldrup
(1989)75
15 Tricyclic antidepressants Mianserin or placebo Decrease in pain compared with placebo only (only 10
patients)
Pheasant
(1983)76
16 Tricyclic antidepressants Placebo Decreased use of analgesia, no significant difference
in activity level
*All changes are significant (P<0.05) unless stated otherwise.
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Chronic fatigue syndrome
Antidepressants in patients with chronic fatigue
syndrome produced no sustained improvement.12 44–46
Irritable bowel syndrome
A meta›analysis of the effect of antidepressants,
regardless of setting, reported a moderate improve›
ment in symptoms.4 Antidepressants seem to be effec›
tive in both primary and secondary care: improve›
ments in physical symptoms and depression were
reported in the study that included primary care
patients and 10 out of 11 studies of 444 secondary care
patients.21–55 We could compare treatment effect sizes in
two of these studies, and these suggest that improve›
ment in pain relief was far greater among secondary
than primary care patients (table 7).21 51 The two studies
in which we could directly compare initial pain severity
suggested that secondary care patients reported only
slightly more severe pain than their counterparts in
primary care, and patients in all these studies were
similar in terms of symptom chronicity and age (table
5).21 51
Treatments with uncertain effectiveness in primary
care patients
The effectiveness of cognitive behaviour therapy in
patients with chronic fatigue syndrome and irritable
bowel syndrome has been measured in patients in both
primary and secondary care but differences in
treatment regimens limit the conclusions that can be
drawn. Cognitive behaviour therapy has been effective
in patients with chronic fatigue syndrome in secondary
care, although brief cognitive behaviour therapy was
ineffective.56–59 In primary care patients, there was no
difference in effectiveness between brief therapy and
counselling (table 7).60
Three studies of 169 primary care or community
patients and five studies of 171 secondary care patients
examined the effectiveness of cognitive behaviour
therapy for irritable bowel syndrome.13 14 16 61–65 All the
secondary care studies reported significant improve›
ments with cognitive behaviour therapy in symptoms
and in coping.61–65 The two smaller primary care studies
reported greater symptomatic improvement with cog›
nitive behaviour therapy than in controls, but in the
largest study cognitive behaviour therapy was no better
than placebo. There were insufficient data to draw con›
clusions about treatment effectiveness in primary care
for behaviour therapy in patients with chronic fatigue
syndrome (promising results were reported in second›
ary care) and for behaviour therapy and brief
psychodynamic therapy in patients with irritable bowel
syndrome. 15 45 66–74
Discussion
We found little or no research on the effectiveness of
some interventions, such as brief psychodynamic inter›
personal therapy. However, meta›analyses suggest that
behaviour therapy is effective for chronic back pain
and that antidepressants are effective for irritable
bowel syndrome. Analysis of individual studies
indicates that cognitive behaviour therapy and
behaviour therapy for patients with back pain is more
effective in patients in secondary care than those in
primary care; antidepressant treatment for irritable
bowel syndrome may also be more effective in second›
ary care. It should not, therefore, be assumed that
interventions which are effective in secondary care will
produce the same magnitude of effect in primary care.
Table 4 Number of comparisons conducted in each treatment setting
Studies from primary care or the
community Studies from secondary care
Chronic fatigue syndrome:
Cognitive behaviour therapy*† 1 4
Behaviour therapy† 0 3
Brief dynamic psychotherapy 0 0
Antidepressants 1 3
Irritable bowel syndrome:
Cognitive behaviour therapy*† 3 5
Behaviour therapy† 2 2
Brief dynamic psychotherapy 0 2
Antidepressants 1 11
Chronic back pain
Cognitive behaviour therapy*† 7 9
Behaviour therapy*† 9 6
Brief dynamic psychotherapy 0 0
Antidepressants 0 2
*Cognitive therapy is included in the category cognitive behaviour therapy as we were unable to distinguish
the two in the published studies.
†Some studies compared cognitive behaviour therapy with behaviour therapy as well as cognitive behaviour
therapy with a control and behaviour therapy with a control intervention. These studies have been included
more than once.
Box 2: Summary of research findings for
effectiveness of mental health interventions for
patients with somatic symptoms in primary and
secondary care
Chronic fatigue syndrome
Cognitive behaviour therapy—Seems to be effective in
secondary care patients. One study suggests a lack of
supremacy of cognitive behaviour therapy over
counselling in primary care patients
Behavioural therapy—Some evidence of effectiveness of
graded exercise in secondary care patients
Brief psychodynamic interpersonal therapy—No trials
identified
Antidepressants—No evidence for sustained
symptomatic improvement in primary or secondary
care patients
Irritable bowel syndrome
Cognitive behaviour therapy—Mixed results. In studies
that showed effectiveness (in both settings), this may
reflect the training and experience of the therapist,
rather than the efficacy of the intervention.
Behavioural therapy—Limited evidence for the
effectiveness of relaxation training in primary care
patients
Brief psychodynamic interpersonal therapy—Some
evidence of effectiveness in secondary care refractory
patients
Antidepressants—Seems to be effective in primary and
secondary care patients
Chronic back pain
Cognitive behaviour therapy—Seems to be effective in
primary and secondary care patients
Behavioural therapy—Seems to be effective in primary
and secondary care patients
Brief psychodynamic interpersonal therapy—No trials
identified
Antidepressants—Insufficient evidence to allow
conclusions to be drawn
Primary care
page 6 of 11 BMJ VOLUME 325 9 NOVEMBER 2002 bmj.com
Instead, these findings need to be replicated independ›
ently in primary care patients.
Limitations of the evidence
For most treatments, we could draw only qualified con›
clusions because of methodological weaknesses in the
research conducted. A major limitation of all the stud›
ies is that they evaluated the effect of interventions
delivered by specialist therapists rather than primary
care staff (box 3). Yet the main burden of disease occurs
in primary care, and patients are unlikely to be referred
to specialists because many would find it unacceptable
and there is often a shortage of specialist resources.
There was sometimes insufficient detail for us to be
sure how the intervention was implemented and
whether it was provided in a standardised way. Only
eight studies stated that a treatment manual was used,
and only two studies (by the same author) monitored
adherence to the protocol.16 17 20 25 26 36 37 42 Quality
checks were hardly ever mentioned; at best there was
rating by an independent assessor to check that the
intervention and control condition were distinct and
intervention credibility checks.13 56 60 63 68 There was
also a lack of data on characteristics of the patients.
Age and symptom duration were usually the only data
provided. Dropout rates and their causes were rarely
given. 12 16 19 28 29 44 46 48 52–54 56 67 71 75
There were few studies of long term outcome. Most
studies (79%) measured only immediate outcome.
Longer term outcome studies would provide evidence
of sustained effectiveness and reduce the possibility of
non›specific effects such as those due to therapist
attention or patient expectations.82 Cost effectiveness is
Table 5 Health state before treatment in patients in primary care and secondary care studies (higher scores indicate greater severity
for all measures except coping skills questionnaire)
Health status measure
Primary care Secondary care
Study Mean score (95% CI) Study Mean score (95% CI)
Back pain:
Coping skills questionnaire Newton›John17 50.0 (42.9 to 57.2) Nicholas30 36.0 (18.5 to 53.5)
Nicholas29 35.4 (28.3 to 42.5)
Visual analogue scale (pain) Donaldson38 27.4 (20.0 to 34.8) Turner43 56.0 (47.6 to 64.3)
Linton41 37.5* Vlaeyen28 67.4 (63.5 to 71.4)
Turner19 54.5 (50.4 to 58.6)
Beck depression inventory Linton41 8.6* Vlaeyen28 13.3*
Turner19 10.7 (9.4 to 12.0) Turner43 14.6 (12.4 to 16.9)
Newton›John17 12.3 (10.1 to 14.5) Nicholas30 18.9 (14.7 to 23.1)
Nicholas29 20.2 (18.2 to 22.3)
Pain beliefs† Newton›John17 41.5 (36.5 to 46.4) Nicholas30 53.6 (43.4 to 63.9)
Nicholas29 66.2 (61.8 to 70.7)
Sickness impact profile Turner20 8.5 (6.8 to 10.2) Turner43 17.4 (14.5 to 20.3)
Turner19 12.2 (10.5 to 13.9) Nicholas29 30.3 (27.9 to 32.7)
Turner 37 17.2 (14.4 to 19.9) Nicholas30 31.5 (25.6 to 37.4)
State trait anxiety inventory (state) Newton›John17 39.5 (36.2 to 42.8) Nicholas29 50.8 (47.6 to 54.0)
Chronic fatigue syndrome:
Hospital anxiety and depression (anxiety) Ridsdale61 9.7 (9.0 to 10.4) Sharpe59 7.4 (6.3 to 8.4)
Hospital anxiety and depression
(depression)
Ridsdale61 7.6 (7.0 to 8.1) Sharpe59 6.8 (5.8 to 7.7)
Irritable bowel syndrome:
Beck depression inventory Blanchard 15‡ 10.9 (9.3 to 12.5) Lynch69 10.3*
Greene14 11.2 (8.5 to 13.9)
Payne13 12.5 (10.5 to 14.6)
Blanchard16 § 13.7 (10.9 to 16.6)
State trait anxiety inventory (trait) Blanchard ‡ 46.9 (44.8 to 49.1) Lynch69 46.2*
Greene14 47.0 (42.7 to 51.3)
Payne13 48.5 (46.3 to 50.6)
Blanchard16 § 48.2 (45.7 to 50.8)
Visual analogue scale (pain) Myren 21 45.2* Tanum52 49.8 (44.8 to 54.8)
*Confidence interval not available.
†High score indicates stronger adherence to maladaptive beliefs.
‡ Large study.
§Small study.
Table 6 Standardised treatment effect sizes immediately after treatment for studies
comparing intervention against control for back pain. Negative effect sizes indicate a
benefit of treatment over control. Effect sizes with two or more references (shown in
superscript) are aggregated
Health measure
Effect size (95% CI)
Cognitive behaviour therapy Behaviour therapy
Coping skills questionnaire:
Primary care −0.29 (−1.04 to 0.47)17 −0.26 (−1.01 to 0.49)17
Secondary care −0.73 (−1.31 to −0.15)29 30 −0.08 (−0.76 to 0.60)29 30
Pain (visual analogue scale):
Primary care −0.29 (−0.86 to 0.28)19 −0.52 (−0.96 to −0.09)19 38
Secondary care −1.82 (−2.84 to −0.80)43 −1.67 (−2.65 to −0.69)43
Beck depression inventory:
Primary care 0.11 (−0.35 to 0.56)17 19 −0.56 (−1.08 to −0.05)17 19
Secondary care −0.30 (−0.78 to 0.18)29 30 43 −0.64 (−2.14 to 0.85)29 43
Pain beliefs:
Primary care −0.78 (−1.56 to 0.00)17 −0.96 (−1.76 to −0.17)17
Secondary care −0.34 (−0.91 to 0.22)29 30 −0.60 (−1.30 to 0.10)30
Sickness impact profile:
Primary care −0.08 (−0.49 to 0.33)19 20 −0.42 (−0.76 to −0.08)19 20 37
Secondary care −0.67 (−1.14 to −0.19)19 20 43 −0.80 (−1.33 to −0.27)29 43
State trait anxiety scale:
Primary care −0.26 (−1.01 to 0.50)17 −0.43 (−1.19 to 0.33)17
Secondary care −0.27 (−0.93 to 0.40)29 −0.23 (−0.87 to 0.41)29
Effect sizes are estimated as the difference in scores after treatment.
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likely to be an important motivator for changing prac›
tice, but only one study examined this.83
Patients with the conditions we studied characteris›
tically have symptoms for many years, and such
patients are likely to be frequent attenders in primary
care. If, as shown for patients with other conditions, the
effect of cognitive behaviour therapy continues to
improve with time, it could be a highly cost effective
intervention.84
Another methodological shortcoming was that
studies were commonly not powerful enough to detect
clinically important differences. Sample sizes were
often less than 20 patients.14 30 46 50 64 68 75 76 77 80 In
addition, many different outcome measures were
used, which limited the number of comparisons
that could be made between settings. Finally, the
studies commonly had problems of internal validity—
for example, the absence of strict randomisation
and of blind assessment of observer rated
outcomes.18 28–35 39 40 43 50 52 53 55 59 61–63 70 71 75 73 74 78
Explanations for findings
We identified four factors that may contribute to the
greater improvements seen in secondary care than pri›
mary care. The first factor relates to differences
between patients in the two settings. Patients in
secondary care were more severely ill than their
primary care counterparts (for cognitive behaviour
therapy and behaviour therapy in back pain). Other
unaccounted patient differences may explain the
greater improvement in secondary care than primary
care for patients with irritable bowel syndrome taking
antidepressants. The second factor concerns differ›
ences in the treatment regimen. In the two studies of
antidepressants in irritable bowel syndrome for which
we could compare treatment effect sizes, the minimum
therapeutic dose was used in the primary care study,
whereas a dose exceeding the recommended maxi›
mum dose was used in the secondary care study.46 50
Similarly, primary care patients with chronic fatigue
syndrome received just four hours of cognitive behav›
iour therapy whereas secondary care patients received
16 hours of treatment.58 60 The third factor concerns
differences in treatment provision: for cognitive behav›
iour therapy in irritable bowel syndrome, studies that
reported an improvement used fewer therapists, most
of whom were supervised by doctors, than studies that
found no effect. The final factor is concerned with dif›
ferences in study design. In the studies of behaviour
therapy for back pain, the control group in the second›
ary care setting was assigned to the waiting list, whereas
Coping skills questionnaire
  Newton-John 1995
  Nicholas 1992
  Nicholas 1991
Visual analogue scale (pain)
  Turner 1993
  Turner 1982
Beck depression inventory
  Newton-John 1995
  Turner 1993
  Nicholas 1992
  Turner 1982
  Nicholas 1991
Pain beliefs questionnaire
  Newton-John 1995
  Nicholas 1991
  Nicholas 1992
Sickness impact profile
  Turner 1993
  Turner 1988
  Nicholas 1991
  Nicholas 1992
  Turner 1982
State trait anxiety inventory
(state)
  Newton-John 1995
  Nicholas 1991
-3.0 -2.5 -2.0 -1.5 -1.0 -0.5 0 0.5 1.0
Fig 1 Standardised treatment effects and 95% confidence intervals
for cognitive behaviour therapy versus control interventions in
patients with back pain (negative effect sizes indicate a benefit for
cognitive behaviour therapy)
Coping skills questionnaire
  Newton-John 1995
  Nicholas 1991
Visual analogue scale (pain)
  Donaldson 1994 (biofeedback)
  Turner 1993
  Donaldson 1994 (relaxation)
  Turner 1982
Beck depression inventory
  Newton-John 1995
  Turner 1993
  Nicholas 1991
  Turner 1992
       (random effects)
Pain beliefs questionnaire
  Newton-John 1995
  Nicholas 1991
Sickness impact profile
  Turner 1988
  Turner 1990
  Turner 1993
  Nicholas 1991
  Turner 1982
State trait anxiety inventory
(state)
  Newton-John 1995
  Nicholas 1991
-3.0 -2.5 -2.0 -1.5 -1.0 -0.5 0 0.5 1.0
Standardised mean difference
Fig 2 Standardised treatment effects and 95% confidence intervals
for behaviour therapy versus control interventions in patients with
back pain (negative effect sizes indicate a benefit for behaviour
therapy)
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in the primary care study they were provided with an
educational package that could be regarded as an
active treatment.38 43
Implications
Pragmatic studies of the effectiveness of psychological
interventions in primary care and on unselected
patients are needed to provide a basis for decisions
about healthcare provision.85 Studies should identify
which elements of an intervention require specialist
training and which require specialist intervention.
They should also measure the effectiveness of
interventions carried out by primary care staff after a
realistic amount of training and with the aid of
standard manuals for patients and practitioners.86
The standards of reporting of trials need to be
improved and harmonised to ensure that sufficient
information is provided. The revised CONSORT crite›
ria provide general guidance on trial reporting but
more detailed directions are required when describing
complex mental health interventions (box 4).87 As well
as precise details of the intervention, baseline clinical
data and data about participants deemed ineligible
should be provided to inform decisions about the
extrapolation of the findings to other people with the
condition.
Trials of mental health interventions should meas›
ure cost effectiveness and long term outcomes.
Although outcomes and illness presentations are multi›
faceted and often difficult to encapsulate in one or two
rating scales, this does not negate the need to rational›
ise the use of outcome instruments. Where possible,
well tested instruments should be used and a primary
outcome measure salient to both patients and
clinicians should be selected. The use of both generic
instruments, such as the SF›36, and of disease and
symptom specific instruments should be considered.88
Trials of effectiveness should be accompanied by quali›
tative research on the health beliefs and attitudes of
participants and non›participants. This will enable
interventions to be tailored to improve recruitment
and dropout rates.
Study designs should include an appropriate
randomisation method, blind assessment of outcomes,
and consistent handling of dropouts from each
group. Whenever possible, the only difference in care
between study groups should be the intervention being
studied.
Table 7 Treatment effect sizes for chronic fatigue syndrome and irritable bowel syndrome in studies comparing intervention against
control immediately after treatment and follow up. Positive effect sizes indicate a benefit of treatment over control
Health status measure Effect size (95% CI) Length of follow up (months)
Cognitive behaviour therapy for chronic fatigue syndrome
Hospital anxiety and depression (anxiety):
Primary care 0.95 (−0.5 to 2.4)60 6
Secondary care 0.6 (−1.1 to 2.2)58* 5
Hospital anxiety and depression (depression):
Primary care −0.13 (−1.6 to 1.4)60 6
Secondary care 1.7 (−0.1 to 3.6)58* 5
Cognitive behaviour therapy for irritable bowel syndrome
Beck depression inventory:
Primary care 3.6 (−1.0 to 8.2)13 3
Secondary care −3.0†63 3›4
State trait anxiety inventory (trait):
Primary care 3.5 (−1.6 to 8.6)13 3
Secondary care −7.6†63 3›4
Antidepressants for irritable bowel syndrome
Visual analogue score (pain):
Primary care 5.121† After treatment
Secondary care 25.9 (13.0 to 38.8)51 After treatment
*Difference in change score (before treatment to follow up).
†Confidence intervals could not be calculated because no measures of variation were reported.
Box 3: Randomised trials of mental health
interventions for somatic conditions:
methodological shortcomings and how they
should be overcome.
1. Dearth of studies in primary care settings, with
intervention provided by members of the primary care
team ( doctor, nurse, counsellor) or lay person
→ Identify elements of interventions which can be
conducted in primary care and conduct pragmatic
trials in primary care, by primary care professionals,
on unselected patients
2. Inadequate information about the content and
quality of the intervention and the comparison group
→ Use treatment manual and quality checks
3. Lack of data on characteristics of the patient sample
→ Conduct exploratory phase to assess illness
attributions. Use results to increase recruitment and to
reduce drop outs, and to tailor intervention to the
beliefs and attitudes of the patients
→ Collect data on participants, non›eligible patients
and drop outs
4. Limited assessment of outcome: short term only, no
cost effectiveness data
→ Measure long term health outcomes in each group
→ Conduct economic analyses as part of trial
5. Studies commonly not powerful enough to detect
clinically important differences with high precision.
→ Undertake power calculations to enable clinically
important differences to be detected and measured
with high precision
6. Great diversity of measurement instruments used
→ Limit the use of health outcome measures to
validated instruments. Use generic and symptom or
disease specific measures
7. Problems of internal validity
→ Address causes of selection, performance, detection
and attrition bias
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Conclusion
Research from both primary and secondary care
suggests that that cognitive behaviour therapy and
behaviour therapy may help patients with back pain
and that patients with irritable bowel syndrome may
improve with antidepressants but effect sizes tend to be
larger in secondary care. Thus, it cannot be assumed
that results from secondary care can be extrapolated to
primary care. The quality and amount of evidence on
mental health interventions for back pain, chronic
fatigue syndrome, and irritable bowel syndrome is
sometimes poor.
This study is part of a research programme examining the
methods of group decision making for developing clinical
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